Clinical Trial Update: The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating human umbilical cord mesenchymal stem cells (iSCLife®-ONFH) for early-stage osteonecrosis of the femoral head has been suspe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• iSCLife®-ONFH (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Osteonecrosis of Femoral Head | Phase 1, Phase 2 | Status: SUSPENDED